Home › Diabetic Kidney Problems › Illinois › Chicago
Diabetic Kidney Problems clinical trials in Chicago, IL
4 studies for Diabetic Kidney Problems are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate Safety, Tolerability, PK, and PD of AZD4248 in Healthy Participants, Participants With CKD and Type 2 Diabetes, Assess Home Measurements of Creatinine in a Non-Interventional Cohort, and Assess the Effect of AZD4248 on the PK of Midazolam and Metformin in Healthy Participants
RecruitingPhase 1Healthy volunteers welcome
- Research Site, Chicago
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
RecruitingPhase 2
- Research by Design, LLC - Internal Medicine, Chicago
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
RecruitingPhase 3
- Northwestern University Feinberg School of Medicine, Chicago
Transformative Research in Diabetic Nephropathy
RecruitingObservational study
- Northwestern University, Chicago
About Diabetic Kidney Problems
Diabetes is the most common cause of kidney failure in the U.S. Kidney damage from Diabetes is called Diabetic Nephropathy.
More about Diabetic Kidney Problems on MedlinePlus
Diabetic Kidney Problems trials in other cities
- Seattle, WA5 studies
- San Antonio, TX4 studies
- Spokane, WA3 studies
- Philadelphia, PA3 studies
- New York City, NY3 studies
- Aurora, CO3 studies
Other studies in Chicago
- Breast Cancer59 studies
- Non-Small Cell Lung Cancer59 studies
- Cancer (all types)51 studies
- Prostate Cancer45 studies
- Lung Cancer43 studies
- Metastatic Cancer42 studies
- Obesity40 studies
- Ovarian Cancer36 studies
- Colorectal Cancer32 studies
- Stroke31 studies
- Head and Neck Squamous Cell Carcinoma29 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.